Peter Ventre, MD
Psychiatry · Oakland Park, FLNPI 1659569952
Payments from drug & device makers
Across 533 payments — averaging $35,044 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$5.3M
- Sunovion Pharmaceuticals Inc.$2.7M
- AbbVie$2.6M
- Hoffmann-la Roche Limited$2.5M
- Vanda Pharmaceuticals Inc.$2.3M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.5M
- plus $1.8M from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $5,308,525 |
| Sunovion Pharmaceuticals Inc. | 217 | $2,661,288 |
| AbbVie(2 entities) | 109 | $2,611,711 |
| Hoffmann-la Roche Limited | 18 | $2,475,444 |
| Vanda Pharmaceuticals Inc. | 14 | $2,291,822 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $1,508,993 |
| Merck | 20 | $1,022,674 |
| Novartis | 3 | $534,479 |
| Sage Therapeutics, LLC | 18 | $103,772 |
| H. Lundbeck A S | 3 | $32,490 |
| Tolmar, Inc. | 5 | $28,109 |
| Alkermes, Inc. | 10 | $25,403 |
| Sumitomo Pharma America, Inc. | 28 | $17,071 |
| Boehringer Ingelheim International GmbH | 18 | $16,856 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $16,493 |
| Eli Lilly | 7 | $15,648 |
| Johnson & Johnson | 16 | $7,383 |
| Livanova USA, Inc. | 1 | $134 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Corium, LLC | 1 | $122 |
| Brainsway USA Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $12 |
| Orexo US, Inc. | 1 | $11 |
How this compares
$18,678,598 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Oakland Park
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
- Theodore TreeseBoca Raton$8.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.